Press Releases

GlobeNewswire, Inc.

NEW YORK and LONDON and STOCKHOLM and DUBAI, United Arab Emirates and MUMBAI, India, June 15, 2026 (GLOBE NEWSWIRE) -- KingsRock Advisors, LLC, an independent global advisory firm, announced today the continuation of its growth, with a series of...

GlobeNewswire, Inc.

New York, USA, June 15, 2026 (GLOBE NEWSWIRE) -- Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and Rising Disease Burden | DelveInsight The...

GlobeNewswire, Inc.

Company announcement No. 25 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 24, 2026) Copenhagen, Denmark, June 15, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; June 15, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis Investment Management Limited...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital...

EIN Presswire

Medical Simulation Market to Surge from USD 3.25 Billion in 2026 to USD 11.42 Billion by 2035, Powered by Patient Safety Mandate, AI-Adaptive Learning Platforms NY, CA, UNITED STATES, June 8, 2026 /⁨EINPresswire.com⁩/ -- As per Market Research...

EIN Presswire

The casein and caseinate market is projected to grow steadily from US$ 3.8 Bn in 2026 to US$ 6.2 Bn by 2033, registering a CAGR of 5.6% overall LONDON, LONDON, UNITED KINGDOM, June 11, 2026 /⁨EINPresswire.com⁩/ -- The global casein and caseinate...

GlobeNewswire, Inc.

Orocidin's QR-01 demonstrates efficacy in two preclinical periodontitis models; micro-CT confirms reduced bone loss Phase IIa clinical trial in patients planned H1 2027 at the University of Copenhagen Bio-Convert receives toxicity waiver from...

GlobeNewswire, Inc.

Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 – Zealand Pharma A/S...

GlobeNewswire, Inc.

PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory...

GlobeNewswire, Inc.

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone...

GlobeNewswire, Inc.

Company announcement – No. 22 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a...

GlobeNewswire, Inc.

Company announcement No. 23 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 23, 2026) Copenhagen, Denmark, June 8, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

MENAFN

(MENAFN) Danish football star Christian Eriksen collapsed during Denmark's international match against Ukraine on Sunday, triggering an immediate medical response and the suspension of play in scenes that drew instant comparisons to the...

MENAFN

(MENAFN) Danish footballer Christian Eriksen collapsed during an international match between Denmark and Ukraine on Sunday, leading to an immediate medical response and the suspension of play, according to reports.

GlobeNewswire, Inc.

Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved...

GlobeNewswire, Inc.

CHICAGO, June 04, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its proprietary brand, Sky Premium Life, is now...

GlobeNewswire, Inc.

Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future...

GlobeNewswire, Inc.

Company announcement No. 20 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a...

GlobeNewswire, Inc.

Company announcement – No. 19 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 29, 2026 – Zealand Pharma A/S...